Journey Medical shareholders approve 3M share increase and 10-year extension of 2015 stock plan

Journey Medical Corp

Stockholders approved an amendment to the 2015 Stock Incentive Plan adding 3,000,000 shares, for a total of 10,642,857 shares authorized.
Plan expiration extended by 10 years to May 27, 2035.
All five director nominees re-elected; KPMG LLP ratified as auditor for 2024.
Proposals received strong support: ~95% of votes cast for plan amendment, 99.9% for auditor ratification.
The plan amendment became effective immediately upon stockholder approval on June 25, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.